Tarsus Pharmaceuticals, Inc. <TARS.O>: Barclays reinstates coverage with overweight rating; price target $110
TARS•Related News
NatWest provides £190 million green development loan for urbanest London student housing project
NWG•
Flora Food Group owner KKR to kick off €7 billion auction
KKR•
Keller installs 1,000-plus piles for Viridor Thameside energy recovery project at Tilbury Docks
XLI•
Cardiol Therapeutics receives over USD 7 million from warrant exercises
CRDL•
US House to vote on data center power cost bill
XLU•